| Literature DB >> 23837031 |
Yiping Liu1, Jianwei Li, Zhenghong Zhang, Yedong Tang, Zuosong Chen, Zhengchao Wang.
Abstract
Endothelial dysfunction (ED) is an early pathophysiological change in patients with impaired glucose tolerance (IGT) during prediabetes mellitus. This study was designed to test the hypothesis that exercise intervention contributes to the reversal of vascular endothelium-dependent dysfunction in middle-aged patients with IGT. Following exercise intervention, significant changes in endothelin (ET)-1, C-type natriuretic peptide (CNP), ΔDia-P, oral glucose tolerance test (OGTT)2h, fasting insulin, homeostasis model of assessment-insulin resistance (HOMA-IR), body fat percentage, waist circumference and waist to hip ratio were measured. However, no marked changes in carotid artery intima-media thickness (IMT), fasting blood glucose and BMI were observed following exercise intervention. Validity analysis of index changes in the two exercise intervention groups further confirmed there was no change. Exercise intervention increased CNP levels, decreased ET-1 levels and increased ΔDia-P, indicating improved vascular endothelium function. Decreased HOMA-IR following exercise suggests enhanced insulin sensitivity. Exercise intervention also improved glucose metabolism via decreased OGTT2h and fasting insulin. In addition, decreased waist circumference, ratio of waist to hip and body fat percentage following exercise intervention improved changes of body composition, including BMI, body fat and waist circumference. These results indicate that exercise intervention may reverse vascular endothelium-dependent dysfunction in middle-aged patients with IGT. This study also provided direct clinical data supporting the use of exercise intervention to prevent diabetes mellitus (DM) during the early stage.Entities:
Keywords: diabetes mellitus; exercise intervention; impaired glucose tolerance
Year: 2013 PMID: 23837031 PMCID: PMC3702621 DOI: 10.3892/etm.2013.1064
Source DB: PubMed Journal: Exp Ther Med ISSN: 1792-0981 Impact factor: 2.447
Analysis of vascular endothelium functions prior to exercise intervention in patients with IGT.
| Group | n | CNP (pg/ml) | ET-1 (pg/ml) | Carotid artery IMT (mm) | ΔDia-P (%) |
|---|---|---|---|---|---|
| Control | 21 | 14.553±3.296 | 140.829±32.379 | 1.056±0.181 | 10.829±1.597 |
| Walking exercise | 20 | 14.099±2.283 | 141.955±32.797 | 1.051±0.206 | 10.853±1.634 |
| Walking + resistance exercise | 20 | 14.736±4.561 | 148.756±39.149 | 1.039±0.206 | 10.493±1.533 |
| F | 0.019 | 0.306 | 0.038 | 0.324 | |
| P-value | 0.982 | 0.737 | 0.963 | 0.724 |
P<0.05 was considered to indicate a statistically significant result among the three groups. IGT, impaired glucose tolerance; CNP, C-type natriuretic peptide; ET-1, endothelin-1; IMT, intima-media thickness; ΔDia-P, the percentage changes in artery diameter after a 5-min compression.
Analysis of HOMA-IR and glucose metabolism prior to exercise intervention in patients with IGT.
| Group | n | FBG (mmol/l) | OGTT2h (mmol/l) | Fasting insulin (mIU/l) | HOMA-IR |
|---|---|---|---|---|---|
| Control | 21 | 5.771±0.310 | 9.352±0.623 | 27.018±8.009 | 6.967±2.279 |
| Walking exercise | 20 | 5.670±0.264 | 9.345±0.575 | 26.747±8.022 | 6.948±2.288 |
| Walking + resistance exercise | 20 | 5.755±0.265 | 9.345±0.568 | 26.936±7.869 | 6.981±2.241 |
| F | 0.761 | 0.001 | 0.006 | 0.001 | |
| P-value | 0.472 | 0.999 | 0.994 | 0.999 |
P<0.05 was considered to indicate a statistically significant result among the three groups. IGT, impaired glucose tolerance; FBG, fasting blood glucose; OGTT, oral glucose tolerance test; HOMA, homeostasis model assessment; IR, insulin resistance.
Analysis of body composition prior to exercise intervention in patients with IGT.
| Group | n | BMI (kg/m2) | Body fat (%) | Waist circumference (cm) | Waist to hip ratio |
|---|---|---|---|---|---|
| Control group | 21 | 27.211±1.296 | 25.367±2.140 | 91.229±4.791 | 0.899±0.028 |
| Walking exercise | 20 | 27.100±1.283 | 25.415±1.945 | 90.990±4.777 | 0.897±0.027 |
| Walking + resistance exercise | 20 | 26.523±1.259 | 25.630±1.272 | 89.161±4.269 | 0.898±0.023 |
| F | 1.691 | 0.119 | 1.212 | 0.035 | |
| P-value | 0.193 | 0.888 | 0.305 | 0.966 |
P<0.05 was considered to indicate a statistically significant result among the three groups. IGT, impaired glucose tolerance.
Comparison of all indices before and after the exercise intervention in the control group.
| Index | Before intervention | After intervention | t | P-value |
|---|---|---|---|---|
| ET-1 (pg/ml) | 140.829±32.380 | 143.125±40.424 | 0.719 | >0.05 |
| CNP (pg/ml) | 14.553±4.675 | 14.397±4.536 | 0.797 | >0.05 |
| ΔDia-P (%) | 10.830±1.597 | 10.326±1.799 | 0.471 | >0.05 |
| Carotid artery IMT (mm) | 1.056±0.188 | 1.054±0.189 | 0.227 | >0.05 |
| Fasting blood glucose (mmol/l) | 5.771±0.310 | 5.676±0.259 | 2.197 | <0.05 |
| OGTT2h (mmol/l) | 9.352±0.623 | 9.371±0.574 | 0.677 | >0.05 |
| Fasting insulin (mIU/l) | 27.018±8.009 | 26.999±7.904 | 0.247 | >0.05 |
| HOMA-IR | 6.967±2.279 | 7.010±2.249 | 0.289 | >0.05 |
| BMI (kg/m2) | 27.211±1.296 | 27.162±1.283 | 1.214 | >0.05 |
| Body fat percent (%) | 25.367±2.140 | 25.314±1.951 | 0.845 | >0.05 |
| Waist circumference (cm) | 91.229±4.791 | 91.239±4.794 | 0.279 | >0.05 |
| Waist to hip ratio | 0.899±0.028 | 0.898±0.027 | 1.595 | >0.05 |
P<0.05 was considered to indicate a statistically significant result. CNP, C-type natriuretic peptide; ET-1, endothelin-1; IMT, intima-media thickness; ΔDia-P, the percentage changes in artery diameter after a 5-min compression; OGTT, oral glucose tolerance test; HOMA, homeostasis model assessment; IR, insulin resistance.
Comparison of all indices before and after exercise intervention in the walking exercise group.
| Index | Before intervention | After intervention | t | P-value |
|---|---|---|---|---|
| ET-1 (pg/ml) | 141.955±32.797 | 148.006±34.183 | 4.389 | <0.01 |
| CNP (pg/ml) | 14.825±4.622 | 16.275±4.691 | 11.747 | <0.01 |
| ΔDia-P (%) | 10.853±1.635 | 12.653±1.705 | 2.233 | <0.05 |
| Carotid artery IMT (mm) | 1.051±0.197 | 1.048±0.203 | 1.314 | >0.05 |
| Fasting blood glucose (mmol/l) | 5.670±0.564 | 5.585±0.528 | 1.091 | >0.05 |
| OGTT2h (mmol/l) | 9.345±0.575 | 8.825±0.434 | 7.218 | <0.01 |
| Fasting insulin (mIU/l) | 26.747±8.022 | 25.022±6.742 | 5.435 | <0.01 |
| HOMA-IR | 6.948±2.288 | 6.224±2.019 | 7.857 | <0.01 |
| BMI (kg/m2) | 27.138±1.749 | 26.332±1.779 | 1.443 | >0.05 |
| Body fat percent (%) | 25.415±1.945 | 23.850±2.118 | 9.457 | <0.01 |
| Waist circumference (cm) | 90.990±4.777 | 88.313±3.828 | 3.535 | <0.01 |
| Waist to hip ratio | 0.897±0.027 | 0.879±0.025 | 11.307 | <0.01 |
P<0.05 was considered to indicate a statistically significant result. CNP, C-type natriuretic peptide; ET-1, endothelin-1; IMT, intima-media thickness; ΔDia-P, the percentage changes in artery diameter after a 5-min compression; OGTT, oral glucose tolerance test; HOMA, homeostasis model assessment; IR, insulin resistance.
Comparison of all indices before and after exercise intervention in the walking plus resistance exercise group.
| Index | Before intervention | After intervention | t | P-value |
|---|---|---|---|---|
| ET-1 (pg/ml) | 148.756±39.149 | 141.947±36.550 | 2.492 | <0.05 |
| CNP (pg/ml) | 14.736±4.561 | 17.015±4.623 | −9.778 | <0.01 |
| ΔDia-P (%) | 10.493±1.533 | 13.196±2.065 | 2.333 | <0.05 |
| Carotid artery IMT (mm) | 1.039±0.206 | 1.032±0.207 | 1.896 | >0.05 |
| Fasting blood glucose (mmol/l) | 5.755±0.565 | 5.600±0.515 | 1.808 | >0.05 |
| OGTT2h (mmol/l) | 9.345±0.568 | 8.675±0.463 | 11.719 | <0.01 |
| Fasting insulin (mIU/l) | 26.936±7.869 | 24.967±6.922 | 7.855 | <0.01 |
| HOMA-IR | 6.981±2.241 | 6.209±2.035 | 8.680 | <0.01 |
| BMI (kg/m2) | 26.523±1.359 | 25.978±1.286 | 1.252 | >0.05 |
| Body fat percent (%) | 25.630±1.272 | 23.855±1.008 | 11.335 | <0.01 |
| Waist circumference (cm) | 89.161±4.270 | 87.847±3.045 | 2.443 | <0.05 |
| Waist to hip ratio | 0.898±0.023 | 0.884±0.019 | 7.590 | <0.01 |
P<0.05 was considered to indicate a statistically significant result. CNP, C-type natriuretic peptide; ET-1, endothelin-1; IMT, intima-media thickness; ΔDia-P, the percentage changes in artery diameter after a 5-min compression; OGTT, oral glucose tolerance test; HOMA, homeostasis model assessment; IR, insulin resistance.
Analysis of vascular endothelium functions following exercise intervention in patients with IGT.
| Group | n | CNP (pg/ml) | ET-1 (pg/ml) | Carotid artery IMT (mm) | ΔDia-P (%) |
|---|---|---|---|---|---|
| Control group | 17 | 0.156±0.898 | −2.296±14.635 | 0.002±0.029 | 0.004±0.037 |
| Walking exercise | 17 | −1.450±0.552 | −6.051±6.165 | 0.003±0.019 | −0.800±1.602 |
| Walking exercise + resistance exercise | 16 | −2.280±1.043[ | −6.810±12.221[ | 0.007±0.011 | −1.104±2.116 |
| F | 43.003 | 6.479 | 0.508 | 2.924 | |
| P-value | 0.000 | 0.003 | 0.605 | 0.062 |
P<0.05 vs. control group;
P<0.01 vs. control group;
P<0.01 vs. walking exercise group. IGT, impaired glucose tolerance; CNP, C-type natriuretic peptide; ET-1, endothelin-1; IMT, intima-media thickness; ΔDia-P, the percentage changes in artery diameter after a 5-min compression.
Analysis of HOMA-IR and glucose metabolism following exercise intervention in IGT patients.
| Group | n | FBG (mmol/l) | OGTT2h (mmol/l) | Fasting insulin (mIU/l) | HOMA-IR |
|---|---|---|---|---|---|
| Control group | 17 | 0.095±0.199 | −0.019±0.129 | 0.019±0.353 | −0.043±0.681 |
| Walking exercise | 17 | 0.085±0.075 | 0.520±0.322 | 1.725±1.419 | 0.724±0.412 |
| Walking exercise + resistance exercise | 16 | 0.155±0.182 | 0.670±0.256 | 1.970±1.121 | 0.772±0.398 |
| F | 1.093 | 44.299 | 20.911 | 16.159 | |
| P-value | 0.342 | 0.000 | 0.000 | 0.000 |
P<0.01 vs. control group. IGT, impaired glucose tolerance; FBG, fasting blood glucose; OGTT, oral glucose tolerance test; HOMA, homeostasis model assessment; IR, insulin resistance.
Analysis of body composition following exercise intervention in patients with IGT.
| Group | n | BMI (kg/m2) | Body fat (%) | Waist circumference (cm) | Waist to hip ratio |
|---|---|---|---|---|---|
| Control group | 17 | 0.050±0.187 | 0.052±0.284 | −0.010±0.164 | 0.001±0.003 |
| Walking exercise | 17 | 0.305±0.327 | 1.565±0.740 | 2.963±3.749 | 0.018±0.007 |
| Walking + resistance exercise | 16 | 0.345±0.482 | 1.775±0.701 | 1.314±2.404 | 0.014±0.008 |
| F | 1.622 | 49.577 | 6.975 | 37.442 | |
| P-value | 0.310 | 0.000 | 0.002 | 0.000 |
P<0.01 vs. control group.
P<0.05 vs. walking exercise group. IGT, impaired glucose tolerance.